#1. Provided a liquidity facility into a publicly traded, North American VC fund in return for an economic interest in 15 companies along with follow-on capital and investment management agreement • Included Ambit, which was acquired by Daiichi Sankyo for $410M and GeminX acquired by Cephalon for $525M #2. Completed a synthetic secondary of 8 private companies in a North American VC fund along with follow-on capital to support those companies through value milestones • Included Enobia Pharma which was acquired by Alexion for $1.1B